These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 16189258

  • 41. Clinical Guidelines and PTH Measurement: Does Assay Generation Matter?
    Smit MA, van Kinschot CMJ, van der Linden J, van Noord C, Kos S.
    Endocr Rev; 2019 Dec 01; 40(6):1468-1480. PubMed ID: 31081903
    [Abstract] [Full Text] [Related]

  • 42. Comparison of intact, midregion, and carboxy terminal assays of parathyroid hormone for the diagnosis of bone disease in hemodialyzed patients.
    Solal ME, Sebert JL, Boudailliez B, Marie A, Moriniere P, Gueris J, Bouillon R, Fournier A.
    J Clin Endocrinol Metab; 1991 Sep 01; 73(3):516-24. PubMed ID: 1874930
    [Abstract] [Full Text] [Related]

  • 43. An automated 'bio-intact' PTH assay: a step towards standardisation and improved correlation with parathyroid function in renal disease.
    Savoca R, Bock A, Kraenzlin ME, Schmid HR, Huber AR.
    Clin Chim Acta; 2004 May 01; 343(1-2):167-71. PubMed ID: 15115690
    [Abstract] [Full Text] [Related]

  • 44. Standardization of DiaSorin and Roche automated third generation PTH assays with an International Standard: impact on clinical populations.
    Cavalier E, Delanaye P, Lukas P, Carlisi A, Gadisseur R, Souberbielle JC.
    Clin Chem Lab Med; 2014 Aug 01; 52(8):1137-41. PubMed ID: 24670360
    [Abstract] [Full Text] [Related]

  • 45. Calcium-dependent release of N-terminal fragments and intact immunoreactive parathyroid hormone by human pathological parathyroid tissue in vitro.
    el-Hajj Fuleihan G, Chen CJ, Rivkees SA, Marynick SP, Stock J, Pallotta JA, Brown EM.
    J Clin Endocrinol Metab; 1989 Oct 01; 69(4):860-7. PubMed ID: 2778039
    [Abstract] [Full Text] [Related]

  • 46. Full-length versus intact PTH concentrations in pseudohypoparathyroidism type 1 and primary hyperparathyroidism: clinical evaluation of immunoassays in individuals from China.
    Yang Y, Song A, Song A, Hu Y, Jiang Y, Li M, Xia W, Xing X, Cheng X, Wang O.
    Endocrine; 2022 Dec 01; 78(3):605-614. PubMed ID: 36220966
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Intact parathyrin in postmenopausal women.
    Sokoll LJ, Morrow FD, Quirbach DM, Dawson-Hughes B.
    Clin Chem; 1988 Feb 01; 34(2):407-10. PubMed ID: 3342518
    [Abstract] [Full Text] [Related]

  • 53. Parathyroid hormone: what are we measuring and does it matter?
    Blumsohn A, Al Hadari A.
    Ann Clin Biochem; 2002 May 01; 39(Pt 3):169-72. PubMed ID: 12038589
    [Abstract] [Full Text] [Related]

  • 54. PTH: Redefining Reference Ranges in a Healthy Population-The Role of Interfering Factors and the Type of Laboratory Assay.
    Censi S, Iacobone M, Simmini S, Manso J, Franceschet G, Plebani M, Frigo AC, Zaninotto M, Torresan F, De Silvestro G, Scaroni C, Mian C, Camozzi V.
    Int J Endocrinol; 2020 May 01; 2020():1053719. PubMed ID: 32148482
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Evaluation of postural parathyroid hormone change in patients with primary hyperparathyroidism.
    Aydin C, Polat SB, Dirikoc A, Ogmen B, Cuhaci N, Ersoy R, Cakir B.
    Int J Endocrinol; 2014 May 01; 2014():628010. PubMed ID: 25254042
    [Abstract] [Full Text] [Related]

  • 57. In vitro diagnostic company recalls and medical laboratory practices: an Italian case.
    Lima-Oliveira G, Lippi G, Salvagno GL, Brocco G, Guidi GC.
    Biochem Med (Zagreb); 2015 May 01; 25(2):273-8. PubMed ID: 26110040
    [Abstract] [Full Text] [Related]

  • 58. Comparison of 3 third-generation assays for bio-intact parathyroid hormone.
    Ljungdahl N, Haarhaus M, Linder C, Magnusson P.
    Clin Chem; 2006 May 01; 52(5):903-4. PubMed ID: 16638963
    [No Abstract] [Full Text] [Related]

  • 59. PTH Assays: Understanding What We Have and Forecasting What We Will Have.
    Vieira JG.
    J Osteoporos; 2012 May 01; 2012():523246. PubMed ID: 22548199
    [Abstract] [Full Text] [Related]

  • 60. Comparison of two parathyrin (PTH) assays misleading?
    Kao PC, Klee G.
    Clin Chem; 1987 May 01; 33(5):744-5. PubMed ID: 3568388
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.